Ipratropium bromide + salbutamol solution for inhalation in unit dose vials is indicated for the management of reversible bronchospasm associated
with obstructive airway diseases in patients who require more than a single bronchodilator.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education